ID   ELF-153
AC   CVCL_2031
SY   Elf-153; ELF153
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473443
DR   Cosmic; 787427
DR   Cosmic; 975245
DR   Cosmic; 1012064
DR   Cosmic; 1281310
DR   Cosmic; 1465954
DR   Cosmic; 2306197
DR   DSMZ; ACC-693
DR   DSMZCellDive; ACC-693
DR   Wikidata; Q54832241
RX   CelloPub=CLPUB00037;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7488550;
RX   PubMed=7519473;
RX   PubMed=16408098;
RX   PubMed=31160637;
RX   PubMed=36982453;
CC   Part of: LL-100 blood cancer cell line panel.
CC   Characteristics: CSF2 dependent (CelloPub=CLPUB00037; PubMed=7488550).
CC   Doubling time: 36 hours (PubMed=7488550; PubMed=7519473); ~40-60 hours (DSMZ=ACC-693).
CC   HLA typing: A*01:01:01,02:01:01; B*08:01:01,35:01:01; C*07:01:01,07:01:01; DPA1*01:03:01,02:01:01; DPB1*14:01:01,04:02:01; DQB1*03:01:01,03:01:01; DRA*01:01:01,01:01:01; DRB1*09:01:02,11:01:01 (DSMZCellDive=ACC-693).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-693; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 13,14
ST   D12S391: 19
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 12,15
ST   D19S433: 13,14.2 (Technion Genomics Center)
ST   D19S433: 13,15 (DSMZ=ACC-693)
ST   D1S1656: 15.3,16
ST   D21S11: 31,32.2
ST   D22S1045: 16
ST   D2S1338: 18,25
ST   D2S441: 11,14
ST   D3S1358: 17,18 (Technion Genomics Center)
ST   D3S1358: 18 (DSMZ=ACC-693)
ST   D5S818: 11
ST   D7S820: 9,10 (DSMZ=ACC-693)
ST   D7S820: 9.3 (Technion Genomics Center)
ST   D8S1179: 12,13
ST   FGA: 19,23
ST   Penta D: 12,13
ST   Penta E: 12,14
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
RX   PubMed=7488550; PMCID=PMC1997200;
RA   Hassan, Hassan Tawhid
RA   Hanauske, Axel-Rainer
RA   Lux, E.
RA   Kleine, Hans-Dieter
RA   Freund, Mathias
RT   "A new fibroblast growth stimulating activity from the human
RT   megakaryoblastic leukaemia cell line ELF-153: in vitro and in vivo
RT   findings.";
RL   Int. J. Exp. Pathol. 76:361-367(1995).
//
RX   PubMed=16408098; DOI=10.1038/sj.leu.2404081;
RA   Quentmeier, Hilmar
RA   MacLeod, Roderick A.F.
RA   Zaborski, Margarete
RA   Drexler, Hans Gunther
RT   "JAK2 V617F tyrosine kinase mutation in cell lines derived from
RT   myeloproliferative disorders.";
RL   Leukemia 20:471-476(2006).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   CelloPub=CLPUB00037;
RA   Freund, Mathias
RA   Kleine, Hans-Dieter
RA   Lux, E.
RA   Exeriede, G.
RA   Hanauske, Axel-Rainer
RA   Herbst, Hermann
RA   Vainchenker, William
RA   Schweigerer, Lothar
RA   Fonatsch, Christa
RA   Poliwoda, Hubert
RT   "ELF-153: a novel cell line derived from a patient with acute
RT   myelofibrosis and AML.";
RL   Blut 61:128.232-128.232(1990).
//
RX   PubMed=7519473; DOI=10.1182/blood.V84.4.1085.1085;
RA   Mouthon, Marc-Andre
RA   Freund, Mathias
RA   Titeux, Monique
RA   Katz, Andre
RA   Guichard, Josette
RA   Breton-Gorius, Janine
RA   Vainchenker, William
RT   "Growth and differentiation of the human megakaryoblastic cell line
RT   (ELF-153): a model for early stages of megakaryocytopoiesis.";
RL   Blood 84:1085-1097(1994).
//
RX   PubMed=31160637; DOI=10.1038/s41598-019-44491-x; PMCID=PMC6547646;
RA   Quentmeier, Hilmar
RA   Pommerenke, Claudia
RA   Dirks, Wilhelm Gerhard
RA   Eberth, Sonja
RA   Koeppel, Max
RA   MacLeod, Roderick A.F.
RA   Nagel, Stefan
RA   Steube, Klaus G.
RA   Uphoff, Cord C.
RA   Drexler, Hans Gunther
RT   "The LL-100 panel: 100 cell lines for blood cancer studies.";
RL   Sci. Rep. 9:8218.1-8218.14(2019).
//
RX   PubMed=36982453; DOI=10.3390/ijms24065377; PMCID=PMC10049680;
RA   Skopek, Rafal
RA   Palusinska, Malgorzata
RA   Kaczor-Keller, Katarzyna
RA   Pingwara, Rafal
RA   Papierniak-Wygladala, Anna
RA   Schenk, Tino
RA   Lewicki, Slawomir
RA   Zelent, Artur
RA   Szymanski, Lukasz
RT   "Choosing the right cell line for acute myeloid leukemia (AML)
RT   research.";
RL   Int. J. Mol. Sci. 24:5377.1-5377.34(2023).
//